aldumastat   Click here for help

GtoPdb Ligand ID: 12778

Synonyms: GLPG-1972 | GLPG1972 | S201086
PDB Ligand
Compound class: Synthetic organic
Comment: Aldumastat (GLPG1972, S201086) is a clinical lead disease-modifying osteoarthritis agent [1]. It inhibits ADAMTS-5-mediated degradation of the cartilage component aggrecan (AGC). This mechanism is predicted to reduce cartilage degradation in inflammed osteoarthritic joints.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 81.75
Molecular weight 406.43
XLogP 1.21
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C[C@H]1CN(CCN1C2=CC(=CC(=C2)F)F)C(=O)CC[C@]3(C4CC4)C(=O)NC(=O)N3
Isomeric SMILES C[C@H]1CN(CCN1C2=CC(=CC(=C2)F)F)C(=O)CC[C@@]3(C(=O)NC(=O)N3)C4CC4
InChI InChI=1S/C20H24F2N4O3/c1-12-11-25(6-7-26(12)16-9-14(21)8-15(22)10-16)17(27)4-5-20(13-2-3-13)18(28)23-19(29)24-20/h8-10,12-13H,2-7,11H2,1H3,(H2,23,24,28,29)/t12-,20-/m0/s1
InChI Key CMLVKUWQFZQPPS-YUNKPMOVSA-N
No information available.
Summary of Clinical Use Click here for help
GLPG1972 is in clinical evaluations for potential to treat osteoarthritis.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT03311009 A Study With GLPG1972 in Osteoarthritis Subjects Phase 1 Interventional Galapagos NV
NCT03595618 A Study to Assess Efficacy and Safety of GLPG1972/S201086 in Participants With Knee Osteoarthritis Phase 2 Interventional Galapagos NV